SPONSOR
The First Hospital of Jilin University
Total Trials
8
Recruiting
8
Phases
Phase 2
Conditions studied: Recurrent Ovarian CancerPlatinum ResistanceGlioblastomaEndocytoscopyBreast CancerMRDLung Cancer (Diagnosis)Deep Vein Thrombosis (DVT)Venous Thromboembolism (VTE)Acute Ischemic Stroke
The First Hospital of Jilin University is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Recurrent Ovarian Cancer, Platinum Resistance, Glioblastoma, Endocytoscopy.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First Hospital of Jilin University
How many clinical trials has The First Hospital of Jilin University sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by The First Hospital of Jilin University, of which 8 are actively recruiting participants. These trials cover conditions including Recurrent Ovarian Cancer, Platinum Resistance, Glioblastoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First Hospital of Jilin University research focus on?
The First Hospital of Jilin University clinical trials span Recurrent Ovarian Cancer, Platinum Resistance, Glioblastoma, Endocytoscopy, Breast Cancer, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The First Hospital of Jilin University clinical trial?
To participate in a The First Hospital of Jilin University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First Hospital of Jilin University trials with current recruitment status updated daily.
Clinical Trials by The First Hospital of Jilin University
NCT07495384
Recruiting
Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study
Recurrent Ovarian Cancer
NCT06740955
Recruiting
Hypofractionated Radiotherapy
Glioblastoma
NCT06982872
Recruiting
Comparison of the Diagnostic Performance of Different Artificial Intelligence Assisted Endocytoscopy for Colorectal Lesions
Endocytoscopy
NCT06918262
Recruiting
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
Breast Cancer
NCT07439991
Recruiting
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Lung Cancer (Diagnosis)
NCT06045156
Recruiting
Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke
Acute Ischemic Stroke
NCT07119463 Phase 2
Recruiting
Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery
Postoperative Hypoalbuminemia
NCT06957093
Recruiting
Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial
Diabetes Mellitus Type 2 (T2DM)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology